| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |